Takeda profit slumps by half as Japanese drugmaker rebuilds pipeline
TOKYO (Reuters) - Japan's Takeda Pharmaceutical said full-year earnings slumped by more than half as the company focused on rebuilding its drug pipeline to make up for the loss of patent protection for major sellers. Operating profit was 214.1 bill...
11h ago
UK refuses to sign global vaccine treaty, The Telegraph reports
(Reuters) - Britain is refusing to sign the World Health Organization's pandemic accord because the country says it would have to give away a fifth of its vaccines, the Telegraph reported on Wednesday. Britain will only agree to a legally binding g...
18h ago
Ascension warns of suspected cyberattack; clinical operations disrupted
(Reuters) - Hospital operator Ascension reported disruptions to its clinical operations on Wednesday due to a suspected cybersecurity incident and advised business partners to temporarily disconnect from its systems. Earlier this year, UnitedHealth...
20h ago
US FDA recommends healthcare providers switch from Getinge's heart devices
(Reuters) - The U.S Food and Drug Administration on Wednesday recommended healthcare facilities transition away from using Getinge's heart devices as they continued to have safety and quality concerns. (Reporting by Sriparna Roy in Bengaluru; Edit...
May 08, 2024
Google DeepMind unveils next generation of drug discovery AI model
By Martin Coulter LONDON (Reuters) - Google Deepmind has unveiled the third major version of its "AlphaFold" artificial intelligence model, designed to help scientists design drugs and target disease more effectively. In 2020, the company made a si...
May 08, 2024
Teva Pharm Q1 profit misses estimates, revenue risea
By Steven Scheer JERUSALEM (Reuters) - Teva Pharmaceutical Industries reported a smaller than expected rise in first-quarter profit citing higher impairments of tangible assets, while sales of copycat medicines and its branded drugs to treat migrai...
May 08, 2024
Pfizer agrees to settle over 10,000 Zantac lawsuits, Bloomberg News reports
(Reuters) -Pfizer has agreed to settle more than 10,000 lawsuits about cancer risks related to the now discontinued heartburn drug Zantac, Bloomberg News reported on Wednesday, citing people familiar with the deal. The agreements cover cases in U.S. st...
May 08, 2024
Vitamin Shoppe's telehealth service to provide access to weight-loss drugs
(Reuters) - Health and wellness products retailer Vitamin Shoppe said on Wednesday that subscribers to its telehealth service would have access to weight-loss medications such as Ozempic, Mounjaro and Rybelsus. Monthly medication subscription to th...
May 08, 2024
Teva and Medincell's schizophrenia drug meets main goal of late-stage study
(Reuters) -Israel-based Teva Pharmaceuticals and French partner Medincell said on Wednesday their injectable form of a schizophrenia drug had met its main goal in a late-stage study. TEV-'749, an under-the-skin version of a generic antipsychotic drug c...
May 08, 2024
Thai PM says cannabis to be re-listed as narcotic by end of 2024
BANGKOK (Reuters) - Thai Prime Minister Srettha Thavisin said on Wednesday that cannabis would be re-listed as a narcotic by end of 2024, in a stunning U-turn for the country two years after it became the first in the region to decriminalise its re...
May 08, 2024
Europe in whooping cough epidemic as cases soar, says health agency
LONDON (Reuters) - Countries across Europe reported a huge rise in whooping cough cases in 2023 and the first three months of 2024, with ten times as many identified as in each of the previous two years. In total, there were nearly 60,000 cases rep...
May 08, 2024
McKesson misses quarterly estimates as US pharmaceuticals segment weighs
(Reuters) - McKesson Corp reported weaker-than-expected quarterly revenue and profit on Tuesday due to slump in demand for the company's branded and specialty drugs that dragged sales in its U.S. pharmaceutical segment. The drug distributor's pharm...
May 07, 2024
Bio-Rad Laboratories reiterates 2024 revenue growth outlook; shares slip
(Reuters) - Diagnostics firm Bio Rad Laboratories reiterated its 2024 sales growth forecast on Tuesday, weighed by persistently weak spending by biotech companies and sluggish demand in China. The supplier of laboratory apparatus and instruments fo...
May 07, 2024
Pfizer reports patient death in Duchenne gene therapy study
(Reuters) - A young boy died due to a cardiac arrest in a mid-stage trial that tested Pfizer's experimental gene therapy for a muscle-wasting disorder called Duchenne muscular dystrophy (DMD), the drugmaker told Reuters on Tuesday. "A fatal serious...
May 07, 2024
Idaho will seek to revive 'abortion trafficking' law in US appeals court
By Brendan Pierson (Reuters) - Idaho will urge a federal appeals court on Tuesday to revive a 2023 law making it a crime to help a minor cross state lines for an abortion without her parent's consent, which a judge blocked in November. A three-judg...
May 07, 2024
AstraZeneca to withdraw Covid vaccine worldwide, The Telegraph reports
(Reuters) - Anglo-Swedish drugmaker AstraZeneca is withdrawing its Covid vaccine worldwide, The Telegraph reported on Tuesday. The application to withdraw the vaccine was made on March 5 and came into effect on Tuesday, the report added. (Reportin...
May 07, 2024
Bankrupt Steward Health puts its hospitals up for sale, discloses $9 billion in debt
By Dietrich Knauth NEW YORK (Reuters) - Bankrupt Steward Health Care has put all of its 31 U.S. hospitals up for sale, hoping to finalize transactions by the end of the summer to address its $9 billion in total liabilities, its attorneys said at a ...
May 07, 2024
Florida sues Biden administration over new transgender healthcare rule
By Brendan Pierson (Reuters) - Florida's top prosecutor and a Catholic medical group on Tuesday sued the Biden administration in an effort to block a rule that they say will force doctors to provide gender transition care against their judgment or ...
May 07, 2024
US FDA panel to discuss Eli Lilly Alzheimer's drug on June 10
(Reuters) - Eli Lilly said on Tuesday a panel of independent U.S. FDA advisers will discuss whether the agency should approveits Alzheimer's disease drug, donanemab, on June 10. A possible approval for donanemab would pit it against a similar thera...
May 07, 2024
Tylenol maker Kenvue beats quarterly profit estimates, to cut 4% jobs
(Reuters) - Kenvue beat Wall Street estimates for first-quarter profit on Tuesday, and said it would cut 4% of its global workforce amid the Tylenol and Band-Aid maker's efforts to expand its key brands. Since its spinoff from Johnson & Johnson in ...
May 07, 2024
Fresenius Medical beats earnings expectations, keeps outlook; shares sink
By Bartosz Dabrowski (Reuters) - Fresenius Medical Care beat first-quarter operating earnings expectations on Tuesday amid higher pricing and cost-cut savings, but the German company still maintained its profit outlook for 2024, sending its shares ...
May 07, 2024
US Social Security, Medicare finances get slight boost from stronger economy
WASHINGTON (Reuters) - Trust funds supporting Social Security and Medicare benefits for U.S. seniors are showing some improvement due to stronger-than-forecast economic growth, productivity and immigration that is boosting revenue collections, acco...
May 06, 2024
US CDC asks states to make worker protective gear available to combat bird flu
(Reuters) - The U.S. Centers for Disease Control and Prevention (CDC) said on Monday it had met with state health officials and asked them to facilitate distribution of protective gear for farm workers to avoid infection against H5N1 bird flu. The ...
May 06, 2024
US FDA panel to discuss first psychedelic-assisted PTSD treatment next month
(Reuters) - The U.S. Food and Drug Administration's panel of independent advisers will on June 4 deliberate whether they should recommend approval for the first MDMA-assisted therapy for post-traumatic stress disorder, Lykos Therapeutics said on Mo...
May 06, 2024
Vertex tops Q1 profit estimates on robust demand for cystic fibrosis treatments
(Reuters) - Vertex Pharmaceuticals beat Wall Street estimates for first-quarter profit on Monday, driven by robust uptake for its cystic fibrosis treatments. Cystic fibrosis (CF) - an inherited disorder that causes severe damage to the lungs, diges...
May 06, 2024